Efficacy of canakinumab (ACZ885), a fully human anti-Interleukin (IL)-1beta monoclonal antibody, in the prevention of flares in gout patients initiating allopurinol Therapy. - Schlesinger,N.; Lin,HY.; de Meulemeester,M. (Arthritis Rheum, 2010)